Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?

Background and aims: Lipoprotein(a) [Lp(a)] and interleuking-6 (IL-6), an inflammation biomarker, have been established as distinct targets of the residual atherosclerotic cardiovascular disease (ASCVD) risk. We aimed to investigate the association between them, and the potential clinical implicatio...

Descripción completa

Detalles Bibliográficos

Autores principales:	Anastasios Makris, Fotios Barkas, Petros P. Sfikakis, Evangelos Liberopoulos, Theodosios D. Filippatos, Kausik K. Ray, Aris P. Agouridis
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2023-12-01
Colección:	Atherosclerosis Plus
Materias:	Lipoprotein(a) Lp(a) Atherosclerotic cardiovascular disease Interleukin 6 IL-6 IL-6 inhibitor
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2667089523000378
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!